Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a simple header and a Home button, indicating access is blocked. As a result, the study details that would normally appear on the page are not accessible.
    Difference
    20%
    Check dated 2026-09-21T20:24:18.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Update to the page revision shows the record now using v3.6.6, representing a revision bump in the page metadata. The previous v3.6.5 revision was removed, indicating only an internal update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-31T16:14:23.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This appears to be a minor system revision that does not change the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-10T10:47:15.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, representing a new revision of the page content.
    Difference
    0.0%
    Check dated 2026-07-27T05:43:14.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.3 instead of v3.6.2, indicating a new site revision tag. This is an administrative version update and does not modify the study data or available actions.
    Difference
    0.0%
    Check dated 2026-07-05T14:20:40.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2. This reflects a minor update to the page's underlying versioning, likely affecting the template or UI elements without altering the study content.
    Difference
    0.1%
    Check dated 2026-06-28T08:28:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.